These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22427559)

  • 1. Vascular endothelial growth factor gene polymorphisms and choroidal neovascularization in highly myopic eyes.
    Akagi-Kurashige Y; Kumagai K; Yamashiro K; Nakanishi H; Nakata I; Miyake M; Tsujikawa A; Moriyama M; Ohno-Matsui K; Mochizuki M; Yamada R; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2349-53. PubMed ID: 22427559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia.
    Miyake M; Yamashiro K; Akagi-Kurashige Y; Kumagai K; Nakata I; Nakanishi H; Oishi A; Tsujikawa A; Yamada R; Matsuda F; Yoshimura N
    Ophthalmology; 2014 Jan; 121(1):225-233. PubMed ID: 23953100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pigment epithelium-derived factor and complement factor I polymorphisms as a cause of choroidal neovascularization in highly myopic eyes.
    Miyake M; Yamashiro K; Nakanishi H; Nakata I; Akagi-Kurashige Y; Kumagai K; Oishi M; Tsujikawa A; Moriyama M; Ohno-Matsui K; Mochizuki M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4208-12. PubMed ID: 23722394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors for choroidal neovascularization associated with high myopia.
    Leveziel N; Yu Y; Reynolds R; Tai A; Meng W; Caillaux V; Calvas P; Rosner B; Malecaze F; Souied EH; Seddon JM
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5004-9. PubMed ID: 22678500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARMS2/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population.
    Nakanishi H; Gotoh N; Yamada R; Yamashiro K; Otani A; Hayashi H; Tsujikawa A; Shimada N; Ohno-Matsui K; Mochizuki M; Saito M; Saito K; Iida T; Matsuda F; Yoshimura N
    Eye (Lond); 2010 Jun; 24(6):1078-84. PubMed ID: 19680273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis.
    Zhang XJ; Chen XN; Tang FY; Szeto S; Ling XT; Lin ZX; Tham CC; Pang CP; Chen LJ; Yam JC
    Surv Ophthalmol; 2023; 68(6):1011-1026. PubMed ID: 37517683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes.
    Velazquez-Villoria A; Recalde S; Anter J; Bezunartea J; Hernandez-Sanchez M; García-García L; Alonso E; Ruiz-Moreno JM; Araiz-Iribarren J; Fernandez-Robredo P; García-Layana A
    PLoS One; 2016; 11(9):e0162296. PubMed ID: 27643879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization.
    Uematsu S; Sakaguchi H; Sayanagi K; Ikuno Y; Yokoyama A; Asai T; Fukushima Y; Hara C; Sakimoto S; Nishida K
    Sci Rep; 2021 Nov; 11(1):21947. PubMed ID: 34754047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between choroidal morphology and anti-vascular endothelial growth factor treatment outcome in myopic choroidal neovascularization.
    Ahn SJ; Woo SJ; Kim KE; Park KH
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2115-22. PubMed ID: 23462751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macular choroidal thickness assessment with SD-OCT in high myopia with or without choroidal neovascularization].
    El Matri L; Bouladi M; Chebil A; Kort F; Largueche L; Mghaieth F
    J Fr Ophtalmol; 2013 Oct; 36(8):687-92. PubMed ID: 23896210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization.
    Wakabayashi T; Ikuno Y; Oshima Y; Hamasaki T; Nishida K
    J Ophthalmol; 2013; 2013():257381. PubMed ID: 23533702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization.
    Lai TY; Luk FO; Lee GK; Lam DS
    Eye (Lond); 2012 Jul; 26(7):1004-11. PubMed ID: 22595908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
    Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
    Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia.
    Chan NS; Teo K; Cheung CM
    Eye Contact Lens; 2016 Jan; 42(1):48-55. PubMed ID: 26448447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.
    Pakzad-Vaezi K; Mehta H; Mammo Z; Tufail A
    Expert Opin Biol Ther; 2016 Jul; 16(7):873-81. PubMed ID: 26985834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia.
    Ohno-Matsui K; Yoshida T; Futagami S; Yasuzumi K; Shimada N; Kojima A; Tokoro T; Mochizuki M
    Br J Ophthalmol; 2003 May; 87(5):570-3. PubMed ID: 12714395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor gene polymorphisms and risk of neovascular age-related macular degeneration in a Chinese cohort.
    Qu Y; Dai H; Zhou F; Zhang X; Xu X; Zhang X; Bi H; Pan X; Wang H; Jiang H; Yin N; Dang G
    Ophthalmic Res; 2011; 45(3):142-8. PubMed ID: 20847577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of lacquer crack in the assessment of myopic choroidal neovascularization.
    Kim YM; Yoon JU; Koh HJ
    Eye (Lond); 2011 Jul; 25(7):937-46. PubMed ID: 21527958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
    Ahn SJ; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ZIC2, RASGRF1, and SHISA6 genes and high myopia in Japanese subjects.
    Oishi M; Yamashiro K; Miyake M; Akagi-Kurashige Y; Kumagai K; Nakata I; Nakanishi H; Yoshikawa M; Oishi A; Gotoh N; Tsujikawa A; ; Yamada R; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7492-7. PubMed ID: 24150758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.